7 results

• Epogen, Procrit May Increase Heart Attack Damage: Study

  May 17, 2011

  Staff Writers

  The findings of recent research suggest that using the anemia drugs Epogen and Procrit following a heart attack is not...

• Use of Anemia Drugs for Kidney Failure Supported by FDA Panel

  October 19, 2010

  Staff Writers

  Despite a potential risk of stroke associated with the use of Aranesp, Procrit and Epogen, an FDA advisory panel has...

• Procrit and Epogen Recall Issued Over Glass Flakes in Vials

  September 27, 2010

  Staff Writers

  A recall of Epogen and Procrit vials has been issued due to a risk that certain lots of the anemia...

• Anemia Drugs Increase Risk of Heart Problems, Death in Some Cases: Study

  September 20, 2010

  Staff Writers

  The findings of a new study indicate that people with chronic kidney disease and diabetes who respond poorly to certain...

• Aranesp, Epogen and Procrit Blood Clot Risk Confirmed: Study

  November 11, 2009

  AboutLawsuits

  According to new research, the anti-anemia drugs Aranesp, Epogen and Procrit not only increase the risk of blood clots, but...

• Aranesp Increases Risk of Stroke for Some Patients: Study

  November 2, 2009

  AboutLawsuits

  New research suggests that side effects of Aranesp, an anemia drug, could increase the risk of stroke in some patients.

• FDA Reviewing Epogen and Procrit Side Effects After Study Identifies Risk of Death

  September 29, 2008

  AboutLawsuits

  The FDA has issued an “Early Communication” about their ongoing safety review of a potential increased risk of death associated...